1. Mutant IDH1 attenuates hepatic lipogenesis through PTEN dependent pathway.
- Author
-
Zhao, Qingwen
- Subjects
- *
LIPID synthesis , *METABOLIC disorders , *LIPID metabolism , *MUTANT proteins , *DIOXYGENASES , *MALATE dehydrogenase , *LABORATORY mice - Abstract
Mutations in IDH1 (isocitrate dehydrogenases) such as R132H/Q/C, are frequently found in intrahepatic cholangiocarcinoma (IHCC). Mutant IDH1 proteins obtain an abnormal activity converting α-ketoglutarate (αKG) to 2-hydroxyglutarate (2-HG), inhibiting the activity of multiple αKG-dependent dioxygenases, leading to metabolism disorder. Here, we depict a molecular network leading by mutant IDH1, that regulates hepatic lipid embolism using mouse model (KI) with IDH1 R132Q specifically knocked in liver. KI mice appear small and have notably reduced hepatic TG and FFA levels. Technically, mutant IDH1-mediated 2-HG can stabilize PTEN mRNA level probably depending on miR-32, activate Akt-SEBP1c signaling, leading to lipogenesis defect. Our study identifies a new role of oncometabolite 2-HG in inhibiting hepatic lipid metabolism. • IDH1 R132Q knock-in mice show hepatic lipogenesis defect. • Mutant IDH1 curbs hepatic lipogenesis via PTEN-dependent pathway. • 2-HG elevates PTEN mRNA level probably relying on miR-32. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF